» Articles » PMID: 36169416

Formalin Fixation, Delay to Fixation, and Time in Fixative Adversely Impact Copy Number Variation Analysis by ACGH

Overview
Publisher Mary Ann Liebert
Specialty Biotechnology
Date 2022 Sep 28
PMID 36169416
Authors
Affiliations
Soon will be listed here.
Abstract

Although molecular profiling of DNA isolated from formalin-fixed, paraffin-embedded (FFPE) tumor specimens has become more common in recent years, it remains unclear how discrete FFPE processing variables may affect detection of copy number variation (CNV). To better understand such effects, array comparative genomic hybridization (aCGH) profiles of FFPE renal cell carcinoma specimens that experienced different delays to fixation (DTFs; 1, 2, 3, and 12 hours) and times in fixative (TIFs; 6, 12, 23, and 72 hours) were compared to snap-frozen tumor and blood specimens from the same patients. A greater number of regions containing CNVs relative to commercial reference DNA were detected in DNA from FFPE tumor specimens than snap-frozen tumor specimens even though they originated from the same tumor blocks. Extended DTF and TIF affected the number of DNA segments with a copy number status that differed between FFPE and frozen tumor specimens; a DTF ≥3 hours led to more segments, while a TIF of 72 hours led to fewer segments. Importantly, effects were not random as a higher guanine-cytosine (GC) content and/or a higher percentage of repeats were observed among stable regions. While limiting aCGH analysis to FFPE specimens with a DTF <3 hours and a TIF <72 hours may circumvent some effects, results from FFPE specimens should be validated against fresh or frozen specimens whenever possible.

Citing Articles

Comprehensive Analysis of Clinically Relevant Copy Number Alterations (CNAs) Using a 523-Gene Next-Generation Sequencing Panel and NxClinical Software in Solid Tumors.

Gupta V, Vashisht V, Vashisht A, Mondal A, Alptekin A, Singh H Genes (Basel). 2024; 15(4).

PMID: 38674331 PMC: 11049607. DOI: 10.3390/genes15040396.

References
1.
Jacobs S, Thompson E, Nannya Y, Yamamoto G, Pillai R, Ogawa S . Genome-wide, high-resolution detection of copy number, loss of heterozygosity, and genotypes from formalin-fixed, paraffin-embedded tumor tissue using microarrays. Cancer Res. 2007; 67(6):2544-51. DOI: 10.1158/0008-5472.CAN-06-3597. View

2.
Bradley M, Aiello K, Ponnapalli S, Hanson H, Alter O . GSVD- and tensor GSVD-uncovered patterns of DNA copy-number alterations predict adenocarcinomas survival in general and in response to platinum. APL Bioeng. 2019; 3(3):036104. PMC: 6701977. DOI: 10.1063/1.5099268. View

3.
Berg K, Sveen A, Holand M, Alagaratnam S, Berg M, Danielsen S . Gene expression profiles of CMS2-epithelial/canonical colorectal cancers are largely driven by DNA copy number gains. Oncogene. 2019; 38(33):6109-6122. PMC: 6756070. DOI: 10.1038/s41388-019-0868-5. View

4.
Pruitt K, Tatusova T, Maglott D . NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res. 2004; 33(Database issue):D501-4. PMC: 539979. DOI: 10.1093/nar/gki025. View

5.
Chen Y, Chen C . DNA copy number variation and loss of heterozygosity in relation to recurrence of and survival from head and neck squamous cell carcinoma: a review. Head Neck. 2008; 30(10):1361-83. PMC: 3220418. DOI: 10.1002/hed.20861. View